{"id":5229,"date":"2011-10-10T09:00:00","date_gmt":"2011-10-10T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/"},"modified":"2024-09-23T11:22:47","modified_gmt":"2024-09-23T11:22:47","slug":"middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/","title":{"rendered":"Middel tegen longziekte kan progressie T1D vertragen"},"content":{"rendered":"Glassia\u00ae is een middel tegen een longziekte die wordt veroorzaakt door een tekort aan het ontstekingsremmende eiwit Alpha-1 Antitrypsine (AAT). AAT wordt normaal door het lichaam aangemaakt en remt schadelijke activiteit van het immuunsysteem in de longen. AAT kan ook elders in het lichaam ontstekingsreacties en dus reacties van het immuunsysteem tegengaan of modereren. Vermoed wordt dat mensen met Type 1 wel voldoende AAT produceren, maar in een variant die minder actief is. Kamada, een Israelisch biotech bedrijf, is nu klinische tests begonnen met AAT suppletie bij recent gediagnostiseerde Type 1 diabetici.\n\n<a href=\"http:\/\/asweetlife.org\/a-sweet-life-staff\/featured\/lung-disease-drug-may-stop-progression-of-type-1-diabetes\/20402\/\">Lees verder<\/a> ( Engelstalig)","protected":false,"raw":""},"excerpt":{"rendered":"<p>Glassia\u00ae is een middel tegen een longziekte die wordt veroorzaakt door een tekort aan het ontstekingsremmende eiwit Alpha-1 Antitrypsine (AAT). AAT wordt normaal door het lichaam aangemaakt en remt schadelijke activiteit van het immuunsysteem in de longen. AAT kan ook elders in het lichaam ontstekingsreacties en dus reacties van het immuunsysteem tegengaan of modereren. Vermoed [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,187,225],"tags":[],"class_list":["post-5229","post","type-post","status-publish","format-standard","hentry","category-archief","category-behandelen","category-nieuwsbrief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Middel tegen longziekte kan progressie T1D vertragen - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Middel tegen longziekte kan progressie T1D vertragen - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Glassia\u00ae is een middel tegen een longziekte die wordt veroorzaakt door een tekort aan het ontstekingsremmende eiwit Alpha-1 Antitrypsine (AAT). AAT wordt normaal door het lichaam aangemaakt en remt schadelijke activiteit van het immuunsysteem in de longen. AAT kan ook elders in het lichaam ontstekingsreacties en dus reacties van het immuunsysteem tegengaan of modereren. Vermoed [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2011-10-10T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:47+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Middel tegen longziekte kan progressie T1D vertragen\",\"datePublished\":\"2011-10-10T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\"},\"wordCount\":101,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"articleSection\":[\"Archief\",\"Behandelen\",\"Nieuwsbrief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\",\"name\":\"Middel tegen longziekte kan progressie T1D vertragen - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"datePublished\":\"2011-10-10T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Middel tegen longziekte kan progressie T1D vertragen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Middel tegen longziekte kan progressie T1D vertragen - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/","og_locale":"nl_NL","og_type":"article","og_title":"Middel tegen longziekte kan progressie T1D vertragen - Breakthrough T1D","og_description":"Glassia\u00ae is een middel tegen een longziekte die wordt veroorzaakt door een tekort aan het ontstekingsremmende eiwit Alpha-1 Antitrypsine (AAT). AAT wordt normaal door het lichaam aangemaakt en remt schadelijke activiteit van het immuunsysteem in de longen. AAT kan ook elders in het lichaam ontstekingsreacties en dus reacties van het immuunsysteem tegengaan of modereren. Vermoed [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/","og_site_name":"Breakthrough T1D","article_published_time":"2011-10-10T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:47+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Middel tegen longziekte kan progressie T1D vertragen","datePublished":"2011-10-10T09:00:00+00:00","dateModified":"2024-09-23T11:22:47+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/"},"wordCount":101,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"articleSection":["Archief","Behandelen","Nieuwsbrief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/","name":"Middel tegen longziekte kan progressie T1D vertragen - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"datePublished":"2011-10-10T09:00:00+00:00","dateModified":"2024-09-23T11:22:47+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/middel-tegen-longziekte-kan-de-progressie-van-type-1-diabetes-vertragen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Middel tegen longziekte kan progressie T1D vertragen"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5229"}],"version-history":[{"count":1,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5229\/revisions"}],"predecessor-version":[{"id":7362,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5229\/revisions\/7362"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}